UBS Group reiterated their buy rating on shares of Croda International (LON:CRDA) in a research note published on Friday morning, investing.thisismoney.co.uk reports. UBS Group currently has a GBX 5,400 ($70.56) target price on the stock, down from their previous target price of GBX 5,450 ($71.21).
Other equities analysts have also issued research reports about the stock. Berenberg Bank raised their price objective on shares of Croda International from GBX 5,050 ($65.99) to GBX 5,300 ($69.25) and gave the company a buy rating in a research report on Thursday, July 26th. Numis Securities lifted their price target on shares of Croda International from GBX 4,300 ($56.19) to GBX 4,700 ($61.41) and gave the company a hold rating in a research report on Thursday, July 26th. Liberum Capital reissued a hold rating on shares of Croda International in a research report on Wednesday, July 25th. Deutsche Bank reissued a hold rating on shares of Croda International in a research report on Friday. Finally, Citigroup raised shares of Croda International to a neutral rating in a research report on Wednesday, September 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of GBX 4,736.36 ($61.89).
Shares of CRDA opened at GBX 4,823 ($63.02) on Friday. Croda International has a twelve month low of GBX 3,461 ($45.22) and a twelve month high of GBX 4,668 ($61.00).
In other news, insider Tom Brophy purchased 55 shares of the company’s stock in a transaction dated Thursday, September 6th. The shares were bought at an average price of GBX 5,021 ($65.61) per share, with a total value of £2,761.55 ($3,608.45). In the last three months, insiders bought 61 shares of company stock worth $306,875.
Croda International Company Profile
Croda International Plc creates, makes, and sells specialty chemicals in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. It operates in four segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The company offers adhesives; crop protection additives and adjuvants, specialty additives for agricultural films, and seed enhancement and animal health chemicals; lubricant additives, specialty additives for plastics, coatings and polymers, advanced materials, and vehicle cleaning chemicals; and specialty ingredients for skin care, hair care, sun care, self-tanning, color cosmetics, body care, bath and shower, deodorants, anti-perspirants, depilatories, men's grooming, oral hygiene, and baby care applications.
Read More: Are all No-Load Funds Equal?
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.